0.77
0.77 (0%)
As of Apr 17, 2025
Hookipa Pharma Inc. [HOOK]
Source:
Company Overview
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on our proprietary arenavirus platform that is designed to target and amplify T cell and immune responses to fight diseases.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 43 1 890 63 60 |
| Industry | manufacturing |
| CEO | Joern Aldag |
| Website | www.hookipapharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $43.9 |
| Operating Profit | $-51.5 |
| Net Income | $-43.5 |
| Net Cash | $-78.4 |
Profit Ratios
| Gross Margin | $43.9 |
| Operating Margin | -117.1 |
| Profit as % of Revenues | -101% |
| Profit as % of Assets | -35.7% |
| Profit as % of Stockholder Equity | -84.9% |
Management Effectiveness
| Return on Equity | -84.9% |
| Return on Assets | -52.7% |
| Turnover Ratio | 36% |
| EBITA | $-51.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $82.5 |
| Total Liabilities | $31.3 |
| Operating Cash Flow | $-77 |
| Investing Cash Flow | $-0.2 |
| Financing Cash Flow | $-1.3 |
